Each Tuesday, we reverse-engineer a real SaaS company's revenue, profit, CAC, funnels, and its top growth tactic.
Sign up to access all features
Sign up with GoogleSign up with LinkedInAlready have an account? Log in
GetLatka is trusted by 200k+ founders, researchers, and marketers.
No contracts, cancel at any time
Valuation
$63.3M
2024 Revenue
Company empowering patients with their health care data and facilitating patient participation in biomedical research, accelerating the personalized-medicine research options
Last updated
In 2024, Sanguine Biosciences's revenue reached $21.1M. Since its launch in 2010, Sanguine Biosciences has shown consistent revenue growth.
Sanguine Biosciences reached a $63.3M valuation in 2025, set during its M&A Offer round.
| Year | Round | Amount | Valuation | % Sold | Source |
|---|---|---|---|---|---|
| 2025 | M&A Offer | - | $63.3M | - |
| Question | Answer |
|---|---|
| What's your age? | - |
| Favorite online tool? | - |
| Favorite book? | - |
| Favorite CEO? | - |
| Advice for 20 year old self | - |
We do not have customer count information for Sanguine Biosciences yet.
Sanguine Biosciences employs approximately 115 people as of 2026.
Sanguine Biosciences generates an estimated $21.1M in annual revenue.
Sanguine Biosciences was founded by Brian Neman.
The CEO of Sanguine Biosciences is Brian Neman.
Sanguine Biosciences raised $0.
Sanguine Biosciences has 115 employees.
Sanguine Biosciences is headquartered in Woburn, Massachusetts, United States.
All figures on this page are taken directly from interviews or are estimates from public sources and proprietary models. Not financial advice. Read full disclaimer.
Claim this profile
Cassa is a SaaS solution, which has chosen to explore digitalizing the communication between...
Mappedin is a mapping and indoor navigation platform that provides businesses with tools to create...
Developer of a cloud-based online platform designed to help online merchants to manage their orders...
Contents.com is a tech company that developed an artificial intelligence platform based on a...
$21.1M(Est.)
Funding
$0
Team
115
Founded
2010
| Year | Milestone | Source |
|---|---|---|
| 2024 | Sanguine Biosciences Hit $21.1m revenue in June 2024 | Estimated |
| 2010 | Launched with $0 revenue |
| Year | Milestone | Source |
|---|---|---|
| 2024 | Reached 115 employees (December 2024) | |
| 2024 | Reached 119 employees (July 2024) |
If you're the CEO and would like to join the podcast, please DM Nathan Latka on LinkedIn.
